Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Diseases × repotrectinib × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Solitary Fibrous Tumors 1 Sarcoma 1 Neoplasm Metastasis 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Lymphoma 1 Liver Diseases 1 Granuloma, Plasma Cell 1 Glioma 1 Glioblastoma 1

Interventions

repotrectinib 1 ozanimod 1 ledipasvir, sofosbuvir drug combination 1 belinostat 1 Sofosbuvir 1 Ribavirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06352528 2025-10-06

A Study to Assess the Drug Levels of Repotrectinib in Healthy Participants and Participants With Moderate and Severe Hepatic Impairment

Bristol-Myers Squibb

Phase 1 Completed

Liver Diseases, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡